Tag: Vulvar Lichen Sclerosus
AFT Pharmaceuticals spearheads progress in women’s health with Hyloris partnership
AFT Pharmaceuticals announced its partnership with Hyloris Pharmaceuticals, based in Belgium, to develop a novel treatment, HY-091, for Vulvar Lichen Sclerosus (VLS), addressing the critical need for effective solutions in an area where approved treatments are limited.
Featured Article
APS Industrial brings Siemens’ next-gen PLC to Aussie manufacturers
As the manufacturing industry advances towards greater automation and digitalisation, companies are seeking smarter and more efficient control solutions to enhance their operations.
